Amphastar Pharma (AMPH) Tops Q2 EPS by 22c

August 8, 2016 5:14 PM EDT
Get Alerts AMPH Hot Sheet
Trade AMPH Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.23, $0.22 better than the analyst estimate of $0.01. Revenue for the quarter came in at $68 million versus the consensus estimate of $62.1 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment